Related Experiment Videos
[Huntington's disease: clinical and molecular genetics]
H Warita1, Y Shiro, K Kashihara
1Department of Neurology, Okayama University Medical School.
Summary
Huntington's disease (HD) is a neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene. Research reveals a toxic gain of function mechanism and highlights the importance of animal models for therapeutic development.
Area of Science:
- Neurodegenerative diseases
- Genetics of neurological disorders
- Molecular mechanisms of disease
Context:
- Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
- Characterized by motor, cognitive, and psychiatric symptoms.
- Caused by an unstable CAG trinucleotide repeat expansion in the IT15 gene, encoding huntingtin.
Purpose:
- To explore the genetic basis and pathophysiological mechanisms of Huntington's disease.
- To understand the correlation between CAG repeat length and clinical phenotype.
- To investigate the role of mutant huntingtin and its interactions in HD pathogenesis.
Summary:
- Identified an unstable CAG trinucleotide repeat expansion in the huntingtin gene (IT15) as the cause of HD.
- Mutant huntingtin exhibits a toxic gain of function, contributing to disease pathology.
- Huntingtin-interacting proteins and intranuclear aggregates offer insights into HD mechanisms.
Impact:
- Advances understanding of Huntington's disease molecular pathogenesis.
- Provides a foundation for developing targeted therapeutics.
- Emphasizes the critical role of transgenic animal models in HD research and drug testing.